Ass. Prof. PhD Robert Kralovics earned his master’s degree in Molecular Biology and Genetics at Comenius University in Bratislava and later his Ph.D. in Biophysics at the Academy of Sciences of the Czech Republic in Brno. He completed his post-doctoral work on the genetics of myeloproliferative disorders working with Josef Prchal at the University of Alabama in Birmingham, USA. In 2000, Robert joined Prchal’s group as Assistant Professor at Baylor College of Medicine in Houston.

From 2001, he was a project leader with Radek Skoda in Basel, Switzerland. In 2006, Robert joined CeMM Research Center for Molecular Medicine in Vienna, Austria as an independent principal investigator. In 2017, he moved to the Department of Laboratory Medicine at Medical University of Vienna where he is an Assistant Professor in Translational Hematology. Robert Kralovics' research interests lie primarily in myeloproliferative neoplasms (MPNs) and in myeloid malignancies in general. His major achievements so far include the identification of mutations in the JAK2 kinase gene (V617F) and the identification of CALR gene mutations, which play an important role in MPN pathogenesis. His current research focuses on the development of immunotherapy for CALR-positive patients and identification novel therapeutic strategies in MPNs.